Fungicide-driven evolution and molecular basis of multidrug resistance in field populations of the grey mould fungus Botrytis cinerea by Kretschmer, Matthias et al.
Fungicide-Driven Evolution and Molecular Basis of
Multidrug Resistance in Field Populations of the Grey
Mould Fungus Botrytis cinerea
Matthias Kretschmer1., Michaela Leroch1., Andreas Mosbach1, Anne-Sophie Walker2, Sabine Fillinger2,
Dennis Mernke1, Henk-Jan Schoonbeek3¤, Jean-Marc Pradier2, Pierre Leroux2, Maarten A. De Waard4,
Matthias Hahn1*
1Department of Biology, University of Kaiserslautern, Kaiserslautern, Germany, 2UMR1290 BIOGER-CPP, INRA-AgroParisTech, Thiverval-Grignon, France, 3 Institute of
Plant Science, University of Fribourg, Fribourg, Switzerland, 4 Laboratory of Phytopathology, Wageningen University, Wageningen, The Netherlands
Abstract
The grey mould fungus Botrytis cinerea causes losses of commercially important fruits, vegetables and ornamentals
worldwide. Fungicide treatments are effective for disease control, but bear the risk of resistance development. The major
resistance mechanism in fungi is target protein modification resulting in reduced drug binding. Multiple drug resistance
(MDR) caused by increased efflux activity is common in human pathogenic microbes, but rarely described for plant
pathogens. Annual monitoring for fungicide resistance in field isolates from fungicide-treated vineyards in France and
Germany revealed a rapidly increasing appearance of B. cinerea field populations with three distinct MDR phenotypes. All
MDR strains showed increased fungicide efflux activity and overexpression of efflux transporter genes. Similar to clinical
MDR isolates of Candida yeasts that are due to transcription factor mutations, all MDR1 strains were shown to harbor
activating mutations in a transcription factor (Mrr1) that controls the gene encoding ABC transporter AtrB. MDR2 strains had
undergone a unique rearrangement in the promoter region of the major facilitator superfamily transporter gene mfsM2,
induced by insertion of a retrotransposon-derived sequence. MDR2 strains carrying the same rearranged mfsM2 allele have
probably migrated from French to German wine-growing regions. The roles of atrB, mrr1 and mfsM2 were proven by the
phenotypes of knock-out and overexpression mutants. As confirmed by sexual crosses, combinations of mrr1 and mfsM2
mutations lead to MDR3 strains with higher broad-spectrum resistance. An MDR3 strain was shown in field experiments to
be selected against sensitive strains by fungicide treatments. Our data document for the first time the rising prevalence,
spread and molecular basis of MDR populations in a major plant pathogen in agricultural environments. These populations
will increase the risk of grey mould rot and hamper the effectiveness of current strategies for fungicide resistance
management.
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Introduction
Synthetic fungicides are used worldwide that provide protection
of major crops from destruction by fungal plant pathogens [1]. As
a result of repeated fungicide treatments, however, resistant strains
of the pathogens are being selected [2]. Different resistance
mechanisms have been reported that reduce fungicide effective-
ness in field and greenhouse environments. Mutations leading to
changes in the target proteins that are still functional but less
sensitive to the drugs are most common in plant pathogenic fungi.
For example, rapid accumulation of mutations in the gene
encoding ß-tubulin have been observed in a variety of plant
pathogens after introduction of the benzimidazole fungicides,
leading to resistance against these fungicides [3]. Other mecha-
nisms, such as overexpression of the gene encoding the target site
or increased fungicide metabolism have also been described [3–6].
Multidrug resistance (MDR), an important resistance mechanism
in human pathogenic microbes and cancer cells, has often been
correlated with the activity of energy dependent plasma membrane
efflux transporters with low substrate specificity. Mutations leading
to overexpression of individual transporters can result in increased
export and thereby reduced sensitivity to a variety of drug molecules
[7–9]. In fungi, the major types of drug efflux proteins are ATP
binding cassette (ABC) and major facilitator superfamily (MFS)
transporters [10–12]. Constitutive overexpression of the ABC
transporters CDR1 and CDR2, or the MFS transporter MDR1
has been observed in Candida spp. with MDR phenotypes that have
been selected by prolonged fluconazole treatments in humans [13].
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In filamentous fungi, the role of ABC and MFS transporters in
the efflux of natural and synthetic toxicants is well known [14]. For
example, analysis of knock-out mutants revealed that the ABC
transporter AtrB from Aspergillus nidulans and its orthologue AtrB
from Botrytis cinerea transport a wide variety of fungicides as well as
toxins of plant and microbial origins [14–16]. Similarly, the MFS
transporter Mfs1 of B. cinerea was found to mediate efflux of several
fungicides as well as plant derived andmicrobial toxins [17]. Several
efflux transporter genes have been shown to be rapidly induced by
fungicides or natural toxins, such as Mycosphaerella graminicola Atr1
and Atr2, or B. cinerea atrD and atrB [16,18]. Some ABC transporters
have been shown to be involved in plant pathogenesis [19–22]. This
is probably mainly due to the export of plant defence compounds,
for example the Arabidopsis phytoalexin camalexin in the case of B.
cinerea AtrB [22]. For the ABC1 transporter of Magnaporthe grisea,
evidence was provided that it is required for tolerance to oxidative
stress during appressorial penetration [19].
Despite some reports of MDR phenotypes in laboratory
mutants of B. cinerea [16,18] and field strains of Penicillium digitatum
and Mycosphaerella graminicola [23,24], a significant role of MDR in
agricultural environments has not yet been described for plant
pathogens. However, a long term monitoring for fungicide
resistance of B. cinerea initiated in French wine-growing regions
has revealed, in addition to drug specific resistance mechanisms,
the appearance of strains with cross resistance to chemically
unrelated fungicides in the Champagne [4,25,26]. In this report,
we have investigated these strains in further detail and describe the
increasing prevalence of three different MDR populations in
commercial vineyards. We show that their phenotypes are caused
by mutations leading to overexpression of efflux transporters, and
present evidence for long-distance migration of MDR strains from
France to German wine-growing regions.
Results
Increasing occurrence of B. cinerea MDR strains in
commercial vineyards
In 1994, strains with two different MDR phenotypes, formerly
designated AniR2 (here MDR1) and AniR3 (here MDR2),
because of their reduced sensitivity to anilinopyrimidine fungi-
cides, have been identified for the first time in the Champagne
(Fig. 1A) [26]. A third MDR phenotype (MDR3) was first detected
in 2001. Since then, the frequency of MDR strains in the
Champagne steadily increased until 2008, when the three MDR
phenotypes together represented 55% of the total population
(Fig. 1A). In vineyards of the German Wine Road region, a similar
survey of B. cinerea isolates for fungicide sensitivity was performed
for three years. Between 2006 and 2008, increasing MDR
populations were also observed, but in contrast to the Champagne
the MDR1 phenotype was clearly dominating (Fig. 1B). As
previously described [26], MDR1 and MDR2 strains had
overlapping but distinct profiles of increased tolerance to a
number of different classes of fungicides and other drugs (Table 1).
Although the levels of tolerance observed were not as high as
specific resistance mechanisms (e.g. target site mutations), they
were clearly genetically based and heritable and therefore called
resistance throughout this paper. While MDR1 strains showed
considerable resistance levels mainly towards fludioxonil, cypro-
dinil and tolnaftate, MDR2 strains were characterized by
increased resistance to fenhexamid, tolnaftate, cycloheximide
and cyprodinil. MDR3 strains showed the highest levels and
broadest spectrum of resistance against most fungicides tested
(Table 1).
MDR phenotypes show increased efflux transporter
activity and expression
MDR phenotypes in fungi are usually correlated with increased
drug efflux [8]. When the B. cinerea MDR strains were tested, they
showed indeed lower fungicide accumulation than sensitive strains,
indicating increased efflux activity. As previously reported [16],
sensitive strains show a transient accumulation of 14C-fludioxonil,
Figure 1. Isolation frequencies of B. cinerea MDR strains from
French and German wine-growing regions. (A) Appearance of
MDR strains in the Champagne. While MDR1 and MDR2 strains, named
initially AniR2 and AniR3, respectively, were first detected in 1994 [4,25],
MDR3 strains have been observed since 2001. (B) Frequency of MDR
strains in the German Wine Road region.
doi:10.1371/journal.ppat.1000696.g001
Author Summary
Bacterial and fungal pathogens cause diseases in humans
and plants alike. Antibiotics and fungicides are used for
disease control, but the microbes are able to adapt quickly
to these drugs by mutation. Multiple drug resistance (MDR)
is well investigated in human pathogens and causes
increasing problems with antibiotic therapy. Driven by the
continuous use of fungicides in commercial vineyards, three
types of rapidly increasing multidrug resistant populations
of the grey mould fungus Botrytis cinerea have appeared in
French vineyards since the mid 1990s. Using a combination
of physiological, molecular and genetic techniques, we
demonstrate that these MDR phenotypes are correlated
with increased drug efflux activity and overexpression of
two efflux transporters. Just two types of mutations, one in
a regulatory protein that controls drug efflux, and the other
in the gene for an efflux transporter itself, are sufficient to
explain the three MDR phenotypes. We also provide
evidence that a subpopulation of the French MDR strains
has migrated eastward into German wine-growing regions.
We anticipate that by continuous selection of multi-
resistant strains, chemical control of grey mould in the field
will become increasingly difficult.
Multidrug Resistance in Botrytis Field Populations
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followed by efflux of the drug after approximately 30 min, due to
activation of efflux transporters (Fig. 2A). In contrast, two MDR1
strains showed only low initial fludioxonil accumulation. After
addition of the uncoupler CCCP, rapid influx was observed for all
strains indicating the presence of energy-dependent efflux systems
(Fig. 2A) [16]. Similarly, MDR3 strains accumulated little
fludioxonil, while MDR2 strains behaved similar to sensitive
strains (Fig. 2B). These data indicated the presence of a
constitutive efflux system in MDR1 and MDR3 strains. With
14C-bitertanol, all MDR strains showed reduced initial accumu-
lation levels compared to sensitive strains, although this effect was
less pronounced in MDR1 than in MDR2 and MDR3 strains
(Fig. 2B). In accordance with these data, lower accumulation of
tebuconazole and triadimenol by a B. cinerea strain with MDR2
phenotype has been described previously [25]. The specificity of
the uptake experiments was confirmed by experiments with heat-
inactivated germlings, which displayed very high, non-transient
fungicide accumulation (Fig. 2C). The phenotype of MDR1
strains, including the low initial fludioxonil accumulation, was
similar to that of a B. cinerea laboratory mutant which showed
overexpression of the ABC transporter AtrB [16]. AtrB and its
orthologs in other filamentous fungi, including Aspergillus nidulans
and Penicillium digitatum, is a conserved efflux pump that contributes
tolerance to various fungicides and natural antifungal compounds
[14–16,21,22,27,28]. Indeed, atrB was constitutively upregulated
in MDR1 and MDR3 strains, but not in MDR2 strains, showing
50–150 fold overexpression relative to sensitive strains. As
previously reported, high levels of atrB expression were observed
in sensitive strains after 30 min treatment with fludioxonil (Fig. 3)
[16]. Two other genes encoding ABC transporters, atrK and
BMR3, were also upregulated in the absence of drug induction in
MDR1 and MDR3 strains when compared to sensitive strains, but
only 2.5–5 fold (Fig. 3B). To identify efflux transporters that are
specifically upregulated in MDR2 strains, microarray hybridiza-
tions with B. cinerea whole genome chips were performed (data not
shown). These experiments revealed that mfsM2 (Major facilitator
superfamily transporter involved in MDR2), which showed very
weak expression in sensitive and MDR1 strains, was more than
600 fold overexpressed in MDR2 and MDR3 strains (Fig. 3).
Overexpression of transporter genes is responsible for
MDR phenotypes
To confirm a causal relationship between overexpression of
efflux transporters and MDR phenotypes, atrB and mfsM2 mutants
were generated. As described further below, MDR1 strains with
atrB deletions had lost the MDR phenotype. Two MDR2 strains
with mfsM2 deletions had lost increased efflux activity for 14C-
bitertanol (Fig. 4A). Furthermore, the mfsM2 deletion mutants had
lost the reduced sensitivity to various fungicides, showing levels
similar to sensitive strains (Fig. 4B, C). In contrast, when a sensitive
strain was transformed with a construct providing constitutive
overexpression of mfsM2 (mfsM2ox), which led to 1481(6309)-fold
upregulation of mfsM2 relative to the parent strain, it acquired
drug resistance levels similar to MDR2 strains (Fig. 4B, C).
Overexpression of atrB and mfsM2 is therefore necessary and
probably sufficient to generate MDR1 and MDR2 phenotypes,
respectively, in B. cinerea field strains. Apart from its role in MDR,
we found only slight growth differences of the mfsM2 deletion
mutants. When tested for pathogenicity, the mfsM2 deletion
mutants showed no significant differences compared to their
parent strains (data not shown).
Mutations leading to changes in gene expression are often
located either in the promoters of these genes, or in regulatory
genes. Sequencing of the atrB promoter regions from several
sensitive, MDR1 and MDR3 strains did not reveal any MDR1-
specific mutations (not shown). Since other ABC-transporter genes
besides atrB were also found to be upregulated in MDR1 and
MDR3 strains (Fig. 3B), we assumed that the MDR1 phenotype
might have been generated by mutations in a regulatory gene. In
order to locate the suspected MDR1-specific regulator gene, a
map-based cloning approach was performed. When F1 progeny
isolates of several crosses with MDR strains were analyzed, the
segregation data confirmed that MDR1 and MDR2 phenotypes
are determined by just one genetic locus each, and that strains
with MDR3 phenotype can originate from recombination between
MDR1 and MDR2 strains (Table S1) [26]. By identifying
polymorphic molecular markers that cosegregate with MDR1
and MDR3 phenotypes in the F1 progeny, it was possible to
localize and identify mrr1 (multidrug resistance regulator 1)
encoding a putative Zn(II)2Cys6 zinc cluster transcription factor
(TF; Table S2) [29]. The genetic marker closest to mrr1, BC63-17,
located 1.8 kb away from mrr1, showed 100 percent cosegregation
with MDR1 phenotypes. Similarly, using crosses with MDR2
strains, a marker located just 1.6 kb away from the efflux
transporter gene mfsM2 was found completely cosegregate with
MDR2 phenotypes, indicating that they are caused by mutations
in mfsM2 (Table S3).
Activating mutations in the Mrr1 transcription factor lead
to MDR1
Sequencing of mrr1 from eight sensitive field strains revealed no
or only silent nucleotide changes when compared to mrr1 of the
Table 1. Classification of B. cinerea MDR strains by their drug sensitivities.
Fludioxonil Fenhexamid Cyprodinil Carbendazim Boscalid Iprodione Tebucoazole Bitertanol Tolnaftate1 Cycloheximide
Sensitive
strains
(EC50: mg/l)
0.0360.01 0.0560.01 0.00660.001 0.0460.01 0.0860.01 1.0360.08 0.6660.31 2.660.65 0.6560.08 3.260.68
Resistance factors (x fold of sensitive)
MDR1 strains 8.1x61.3** 1.6x60.5n.s. 18.2x64.5* 2.8x60.2*** 1.6x60.2n.s. 1.4x60.3n.s. 0.7x60.4n.s. 1.0x60.4n.s. 20.4x62.3*** 0.7x60.1n.s.
MDR2 strains 2.6x60.3*** 9.8x60.6*** 6.2x62.8** 1.1x60.1n.s. 2.0x60.8* 5.4x61.0*** 1.8x60.2* 1.7x60.2* .25x*** 13.7x61.5**
MDR3 strains 11.4x61.9** 14.7x63.2** 25.7x65.2** 3.1x60.5** 3.5x60.9* 6.4x61.0** 2.3x60.6* 1.6x60.1* .25x*** 14.1x60.3***
Mean values from three French and three German isolates each of sensitive strains, MDR1 strains, MDR2 strains, and MDR3 strains are shown. For sensitive strains, EC50
values, and for MDR strains, resistance factors relative to the corresponding values of sensitive strains are shown. 1Due to limited solubility of tolnaftate, accurate values
above 25-fold could not be determined. Significant differences to mean values of sensitive strains: n.s.: Not significant; * p,0.05; ** p,0.01; *** p,0.001.
doi:10.1371/journal.ppat.1000696.t001
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sequenced reference strains T4 and B05.10 (data not shown). In
contrast, all MDR1 (n= 15) and MDR3 (n= 5) strains analyzed
showed at least one point mutation leading to amino acid changes
in Mrr1. In total, at least eight different MDR1-related mutations
were identified (Fig. 5; Table S4). Their role in generation of the
MDR1 phenotype was supported by the observation that five of
these mutations had occurred in more than one MDR1 or MDR3
strain. To confirm that mrr1 encodes the TF responsible for
MDR1-related atrB overexpression, mrr1 and atrB deletions were
generated in MDR1 strains and a sensitive strain. Consistent with
the expected phenotype of a regulatory mutant, mrr1 mutants
showed very low levels of atrB expression, not inducible by
fludioxonil. Furthermore, they showed reduced expression of the
ABC transporter genes BMR3 and atrK that are also upregulated in
MDR1 strains (Fig. 6A). Both the mrr1 and atrB mutants of the
MDR1 strain showed increased fludioxonil uptake, indicating loss
of AtrB-mediated efflux activity (Fig. 6B). With regard to their
drug sensitivity, the mrr1 and atrB mutants of MDR1 strains had
completely lost their MDR1 phenotypes and were slightly
hypersensitive to fludioxonil, similar to previously described atrB
mutants (Fig. 6C, D) [16]. The MDR1 strain D06.7-27 showed an
unusually high cyprodinil resistance and a rather low tolnaftate
resistance, compared to other MDR1 strains, for unknown
reasons. In the D06.7-27(Dmrr1) mutant, the cyprodinil resistance
was significantly reduced, but still higher than in sensitive strains
(Fig. 6C). To confirm that single mrr1 mutations are sufficient for
generation of the MDR1 phenotype, a sensitive strain was
transformed with the mrr1V575M allele from MDR1 strain D06.7-
27. The transformants, expressing both wild type mrr1 and
mrr1V575M, showed constitutive upregulation of atrB and, to a
lower extent, atrK and BMR3 (Fig. 6A), as well as a drug resistance
phenotype similar to MDR1 strains (Fig. 6C, D). The atrB and
Figure 2. Differential fungicide accumulation by B. cinerea sensitive and MDR strains. (A) Kinetics of fludioxonil (14C-labeled) accumulation
by germinated spores of sensitive strain B05.10 (square) and of MDR1 strains D04.375 (circle) and D04.104 (triangle). Addition of carbonyl cyanide m-
chlorophenylhydrazone (CCCP, 10 mM) after 90 min led to a net influx of the fungicide into the cells (dashed lines). (B) Accumulation of 14C-
fludioxonil and 14C-bitertanol by sensitive and MDR strains. Samples were taken 10 min (shaded bars) and 60 min (white bars) after addition of
labeled fungicide. The following strains were analyzed (from left to right): B05.10, D06.6-15 (sensitive); D06.5-16, D04.375 (MDR1); D06.2-6, D06.6-5
(MDR2); D06.7-33, D06.7-39 (MDR3). Significant differences of values (10 min) to those of sensitive strain B05.10 are indicated: n.s.: not significant;
* p,0.05; ** p,0.01; *** p,0.001. (C) Control experiments demonstrating large differences in 14C-fungicide uptake between living and heat-killed
germlings of sensitive (B05.10) and MDR3 (D06.7-33) strains.
doi:10.1371/journal.ppat.1000696.g002
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mrr1 mutants showed only little changes in sensitivity to
fenhexamid, a substrate for MfsM2 but not AtrB, which confirmed
that the functions of AtrB and Mrr1 are fungicide specific. These
data confirmed that Mrr1 is the main transcriptional activator of
atrB, and that activating mutations of mrr1 lead to overexpression
of atrB and thus to MDR1 phenotypes. There are interesting
parallels to the yeasts S. cerevisiae and C. albicans, in which MDR-
related efflux transporter genes are regulated by Zn(II)2Cys6 TFs
as well. C. albicans MDR strains selected by fluconazole treatments
in humans also resulted from gain-of-function TF mutations,
leading to overexpression of ABC- and MFS-type MDR
transporters [13,30].
A unique promoter rearrangement leads to MDR2
Focusing on the search for mutations that are responsible for
mfsM2 upregulation in MDR2 and MDR3 strains, we found a
rearrangement in the mfsM2 upstream region, caused by insertion
of a foreign gene fragment and concurrent deletion of a portion of
the putative mfsM2 promoter. The inserted DNA, 1326 bp in
length, is probably derived from an as yet unknown fungal long-
terminal-repeat (LTR) retrotransposon (Fig. 7A) [31]. Surprisingly,
this sequence is not present in the published genome sequences of
the two B. cinerea strains B05.10 and T4. It encodes truncated
portions of a putative enzyme with domains of reverse transcrip-
tase and RNase H, with closest homologs to sequences in the
REAL retrotransposon of the plant pathogenic fungus Alternaria
alternata [32] and in the Boty retroelement of B. cinerea (Fig. S1)
[33]. Out of 17 MDR2 and MDR3 strains analyzed from the
Champagne (9 strains) and from the German Wine Road (8
strains) by sequencing or PCR analysis, all revealed the identical
mfsM2 promoter rearrangement. In contrast, in 8 sensitive and 15
MDR1 strains no such rearrangement was found (Table S5; data
not shown). This observation strongly suggests that the mfsM2
alleles of these MDR2 and MDR3 strains have a common
progenitor. That the promoter rearrangement is responsible for
mfsM2 overexpression, was supported by the already described
MDR2-like phenotype of a sensitive strain transformed with an
mfsM2 overexpression construct. This was further confirmed by
creating B. cinerea strains expressing mfsM2::uidA reporter gene
fusion constructs. Only with the mfsM2 promoter fragment from
an MDR2 strain, but not with a fragment from a sensitive strain,
strong expression of ß-glucuronidase was observed (Fig. 7B).
MDR3 strains are selected by fungicide treatments in the
field
The rapidly increasing MDR populations in French and
German wine-growing regions indicate that strong selection for
MDR phenotypes occurs by fungicide treatments. This was
confirmed by two field experiments, in which mixtures of an
MDR3 strain and a sensitive strain were introduced into two
vineyards. A single treatment with a commercial fungicide mixture
(fludioxonil and cyprodinil) during early berry development led to
a significantly increased recovery of the MDR3 strain relative to
the sensitive strain during grape harvest (Fig. 8). The recovery
rates of the introduced MDR3 strain were 16% (untreated
vineyard) and 62% (treated vineyard) in 2007, and 34%
(untreated) and 55% (treated) in 2008, while the recovery rates
of the introduced sensitive strain were 26% (untreated) and 14%
(treated) in 2007, and 28% (untreated) and 15% (treated) in 2008.
In addition, the MDR3 strain showed high survival rates after the
following winter periods in the absence of fungicide treatments
(40% in spring 2008, 62% in spring 2009). These data indicate
also that the mutations in mrr1 and mfsM2 do not impair the fitness
of MDR strains to a major extent.
Figure 3. B. cinerea MDR strains show constitutive overexpression of efflux transporter genes. (A) Expression analysis by Northern
hybridization of atrB and mfsM2 in B. cinerea germlings. For hybridization with atrB, RNA of the following strains was loaded (from left to right):
B05.10, D06.6-15 (sensitive, two lanes each); D06.5-16, D06.7-27 (MDR1, two lanes each); D06.6-5, D06.2-6 (MDR2); D06.7-39, D06.7-33 (MDR3). Below
the hybridization signals, the corresponding RNA samples after agarose electrophoresis and ethidium bromide staining are shown as loading
controls. ---: no treatment; +: 30 min treatment with 1 mg/l fludioxonil. For hybridization with mfsM2, RNAs of non-treated germlings were loaded in
the same order as for atrB. (B) Expression analysis by quantitative RT-PCR of efflux transporter genes in sensitive and MDR strains. Values indicate fold-
increases in expression levels, relative to the levels in sensitive strains without fludioxonil treatment (---). Mean values are shown from three strains
each with sensitive, MDR1, MDR2, and MDR3 phenotypes. n.d.: Not determined.
doi:10.1371/journal.ppat.1000696.g003
Multidrug Resistance in Botrytis Field Populations
PLoS Pathogens | www.plospathogens.org 5 December 2009 | Volume 5 | Issue 12 | e1000696
Discussion
Since the introduction of modern fungicides with specific modes
of action, resistance development in fungal field populations has
been observed, notably in B. cinerea which is considered to be a
high risk pathogen [2]. Therefore, rules for fungicide resistance
management have been established that include a recommenda-
tion to avoid the repetitive use of fungicides with similar targets
within one growing season [2,5]. For Botrytis control in commercial
European vineyards, two or three treatments with different mode-
Figure 4. The MfsM2 efflux transporter controls MDR2. (A) Bitertanol (14C-labeled) accumulation after 10 min (shaded) and 60 min (white bars).
Significant differences of values (10 min) of the mutants to those of their MDR2 parent strains are indicated: ** p,0.01. (B) Drug sensitivities. Mean
values of resistance factors relative to B05.10 are shown, from two MDR2 strains (D06.2-6, D06.6-5; white bars), strains D06.2-6(DmfsM2) and D06.6-
5(DmfsM2) (black bars), and from two transformants of strain B05.Hyg-3(mfsM2ox) (grey bars). Significant differences of corresponding values are
indicated betweenMDR2 (DmfsM2) mutants and their parent strains, and between strain B05.Hyg-3(mfsM2ox) and strain B05.Hyg-3: n.s.: Not significant;
* p,0.05; ** p,0.01; *** p,0.001. 1Due to limited solubility of tolnaftate, no accurate values above 25-fold could be determined. Drugs (abbreviated)
are listed in the same order as in Table 1, except for the omission of carbendazim. (C) Drug sensitivity phenotypes on HA plates. 1: D06.2-6(MDR2); 2:
D06.2-6(DmfsM2); 3: B05.10 (sensitive); 4: B05.Hyg-3(mfsM2ox)-4, 5: D06.6-5(MDR2); 6: D06.6-5(DmfsM2); 7: B05.Hyg-3 (sensitive); 8: B05.Hyg-3(mfsM2ox)-
11. Strains with mfsM2 mutations showed a slight growth difference to their parent strains. Pictures were taken 3 d.p.i., except for bitertanol (4 d.p.i.).
Concentrations of drugs were adjusted to reveal clear differences between the strains which overexpress mfsM2 and those which do not.
doi:10.1371/journal.ppat.1000696.g004
Figure 5. MDR1-relatedmutations in the Mrr1 transcription factor. Amino acid positions and exchanges found in MDR1 and MDR3 strains, and
the observed frequencies of each mutation (in parentheses) are indicated. For a detailed list with Mrr1 sequences of individual strains, see Table S4.
doi:10.1371/journal.ppat.1000696.g005
Multidrug Resistance in Botrytis Field Populations
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Figure 6. Mrr1 regulates MDR1 phenotypes via modulation of atrB expression. (A) Expression of ABC transporter genes in strains with
different levels of mrr1 expression. Mean values are shown from two sensitive strains (B05.10, B05.-Hyg3), two MDR1 strains (D06.5-16, D06.7-27), two
MDR1 mrr1 k.o. transformants (D06.5-16(Dmrr1)-5, -7), and two B05.Hyg-3 transformants expressing mrr1V575M (B05.Hyg-3(+mrr1V575M)-5, -6). (B)
Fludioxonil (14C-labeled) accumulation by wild type strains and strains with mutations in atrB and mrr1, after 10 min (shaded) and 60 min (white
bars). Significant differences between the values of the mutants and those of their parent strains are indicated separately for 10 min and 60 min
values (n.s.: not significant; **: p,0.01; ***: p,0.001). (C) Drug sensitivities of atrB and mrr1 mutants. For each mutant, mean values of two or three
transformants were used to calculate resistance factors relative to sensitive strain B05.10 or (in case of B05.Hyg-3(+mrr1V575M) to strain B05.Hyg-3.
#MDR1 strain D06.7-27 showed higher resistance to cyprodinil (standard deviation= 12.0) and lower resistance to tolnaftate, compared to other MDR1
strains. Significantly different resistance values of the transformants relative to their parent strains are indicated (O Not significant; * p,0.05;
** p,0.01; *** p,0.001). 1Due to limited solubility of tolnaftate, no accurate values above 25-fold could be determined. (D) Fungicide sensitivity
phenotypes on agar plates. 1: B05.10 (sensitive); 2: B05.10(DatrB)-4; 3: B05.10(DatrB)-5; 4: B05.10(Dmrr1)-8; 5: B05.10(Dmrr1)-18; 6: D06.5-16 (MDR1); 7:
D06.5-16(DatrB)-1; 8: D06.5-16(DatrB)-2; 9: D06.5-16(Dmrr1)-5; 10: D06.5-16(Dmrr1)-7; 11: B05.Hyg-3 (sensitive); 12: B05.Hyg-3(+mrr1V575M)-5; 13: B05.Hyg-
3(+mrr1V575M)-6; 14: B05.Hyg-3(+mrr1V575M)-10. Top: HA, 2.5 d.p.i.; middle: HA, 0.03 mg/l fludioxonil, 4 d.p.i.; bottom: GB5 (glucose), 0.01 mg/l cyprodinil,
4 d.p.i..
doi:10.1371/journal.ppat.1000696.g006
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of-action fungicides are common. The increasing and widespread
prevalence of MDR strains indicates that they have been selected
under these conditions within the last decade.
The three MDR phenotypes found in French and German
vineyards were clearly correlated with increased drug efflux
activity. Increased fludioxonil efflux was observed for MDR1 and
MDR3 strains but not for MDR2 strains, while bitertanol efflux
was observed for all MDR phenotypes, although more weakly for
MDR1. Furthermore, all MDR strains showed strong constitutive
overexpression of one (MDR1, MDR2) or two (MDR3) drug
efflux transporter genes. In addition, weak overexpression of two
other ABC transporter genes was observed in MDR1 and MDR3
strains. A causal correlation of MDR1 phenotypes with overex-
pression of the ABC transporter atrB, and of MDR2 phenotypes
with MFS transporter mfsM2 overexpression was confirmed by the
analysis of deletion and overexpression mutants. Two MDR1
strains with an atrB mutation had lost the MDR1 phenotype, and
two MDR2 strains with an mfsM2 mutation had lost the MDR2
phenotypes. In addition, a sensitive strain which artificially
overexpressed mfsM2 showed an MDR2-like phenotype. Thus,
overexpression of atrB and mfsM2 are likely to be sufficient for the
observed MDR1 and MDR2 phenotypes in B. cinerea field strains.
While the role of atrB in the export of multiple natural and
synthetic toxicants has been described in detail [14,28], the
function of mfsM2 in sensitive strains remains unknown. The
protein is not highly conserved in other fungi, and even in the
genome sequence of the closely related Sclerotinia sclerotiorum, no
apparent orthologue to B. cinerea mfsM2 could be identified. In
sensitive strains mfsM2 expression is very low, and up to now we
did not find any fungicide or other compounds that induce mfsM2
(data not shown).
In MDR1 strains, the mutations leading to atrB overexpression
were found to be located not in atrB itself, but in the transcription
factor gene mrr1. Out of 20 MDR1 and MDR3 strains analyzed,
all carried mutations in the coding region of mrr1, and several
strains with different geographical origin or collected in different
Figure 7. MDR2 strains carry a retroelement-like gene fragment in the mfsM2 promoter. (A) Structure of the mfsM2 upstream region, and
the insertion-deletion rearrangement (in red) in MDR2 and MDR3 strains. The retroelement-like gene fragment encodes truncated reverse
transcriptase (RT) and RNase H domains. The deleted region is indicated as hatched bar. (B) The rearrangement leads to activation of the mfsM2
promoter. B. cinerea transformants carrying uidA fusions with mfsM2 upstream fragments from strain B05.10 and MDR2 strain D08.2-12 were stained
for ß-glucuronidase activity. Scale bars: 20 mm.
doi:10.1371/journal.ppat.1000696.g007
Figure 8. Field competitiveness of an MDR3 strain is increased
by fungicide selection. Recovery rates of B. cinerea isolates from
inoculated grapevine plants during grape harvest (autumn), and in the
following spring, in two successive years. Fungicide treated (+) and non-
treated (2) grapevine plants were inoculated with a 1:1 mixture of an
MDR3 and a sensitive strain. Grey: Introduced MDR3 strain; White:
Introduced sensitive strain; Black: Resident strains. Significantly different
recovery rates for the introduced strains are shown.
doi:10.1371/journal.ppat.1000696.g008
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years showed identical mutations. Because mrr1 mutants failed to
express atrB to significant levels, and because sensitive strains
expressing an activated version of Mrr1 (Mrr1V575M) showed an
MDR1-like phenotype, Mrr1 was confirmed to be a transcrip-
tional activator of atrB. The mrr1 mutants also showed reduced
expression of atrK and BMR3, when compared to MDR1 strains,
indicating that Mrr1 also plays a role in activation of other efflux
transporter genes. However, since the drug sensitivity phenotypes
of MDR1 strains with either atrB or mrr1 mutations were
indistinguishable from each other, and since MDR1 atrB mutants
have completely lost their MDR1 phenotypes, the weak
overexpression of atrK and BMR3 does not seem to contribute
significantly to the phenotype of MDR1 strains. While our data
indicate that the main physiological role of Mrr1 is regulation of
atrB, the whole set of genes controlled by Mrr1 in the genome of B.
cinerea remains to be determined. Interestingly, while structurally
and also functionally conserved orthologues of B. cinerea AtrB
occur in other ascomycetous fungi, e.g. in A. nidulans, P. digitatum
[15,22], no clear orthologues (best bidirectional hits) of B. cinerea
Mrr1 could be identified in other fungi. This indicates that the
regulation of ABC transporters in filamentous fungi might be not
highly conserved. Similar observations have been made for yeasts,
because the major efflux transporter in S. cerevisiae, PDR5, and its
orthologue pair CDR1/CDR2 in C. albicans, are under control of
different transcription factors [34].
With regard to fungicide resistance, efflux activities, efflux
transporter gene overexpression, and genetic data, MDR3 strains
were clearly identified as recombinants carrying both MDR1-
specific mutations in mrr1 and MDR2-specific mutations in mfsM2.
Collectively, all data indicate that the three MDR phenotypes in B.
cinerea have originated by mutations in just two genes. Obviously,
the different mrr1 point mutations leading to MDR1 have occurred
repeatedly. Thus MDR1 phenotypes could appear (and might
have already appeared) in different agricultural environments in
which selective conditions for these phenotypes prevail. Similarly,
a variety of gain-of-function mutations have been found in
transcription factor genes TAC1 and MRR1 of clinical MDR
isolates of C. albicans, leading to overexpression of the efflux
transporter genes MDR1 and CDR1 or CDR2, respectively
[13,30,35]. In contrast, the rearrangement in the mfsM2 promoter
appeared to be a unique event, found in all MDR2 and MDR3
strains analyzed so far. Based on the time course of appearance of
these strains in the Champagne, and their lower frequency
compared to MDR1 strains in Germany, we assume that the
rearrangement in mfsM2 originated once in the Champagne,
possibly in the early 1990s. The rearranged mfsM2 allele later
spread into the German Wine Road region, 250 km east of the
Champagne, possibly by air currents. Because of the small size of
the retrotransposon-derived gene fragment and of the lack of any
remaining LTR sequences, the origin of the sequence inserted into
mfsM2 and the mechanism of the insertion-deletion rearrangement
remain obscure. The absence of the integrated sequence in the
published genomes of strains B05.10 and T4 indicates that it
occurs only in subpopulations of B. cinerea. A search for the
presence of the sequence in a variety of field strains by using PCR,
Southern hybridization and sequencing revealed that similar but
non-identical sequences are present in some sensitive strains (data
not shown). The mfsM2 mutation is reminiscent of a transposable
element insertion into the promoter of a gene for a cytochrome
P450 monooxygenase involved in insecticide detoxification and
resistance in Drosophila, leading to overexpression and global
spread of the mutated gene [36].
A summarizing model of the data in this paper is shown in
Fig. 9. It is assumed that MDR strains in the Champagne have
appeared due to selection pressure in fungicide treated vineyards,
and to mutations leading to the appearance of MDR1 and MDR2
strains, and a few years later also to the appearance of MDR3
strains. Because a repeated occurrence of the unusual rearrange-
ment found in the mfsM2 promoter appears to be highly unlikely,
we assume that MDR2 strains carrying this rearrangement have
migrated from France to Germany, probably in the last decade.
To support this hypothesis, population genetic studies with MDR
strains from different geographical origins are currently per-
formed. In addition, we are searching for MDR strains in other
regions with different crop cultures and different fungicide
treatment schedules, in order to achieve a better understanding
of the distribution of MDR strains, and the factors leading to their
appearance and selection.
A field experiment has clearly demonstrated selection of an
artificially introduced MDR3 strain by a standard fungicide
treatment. This confirms that the MDR3 phenotype confers
selective advantage to B. cinerea in fungicide-treated vineyards, and
that this advantage outweighs possible fitness defects. Further-
more, the MDR3 strain was recovered with high albeit varying
frequencies after overwintering periods, in the absence of fungicide
selection pressure. These data indicate that the general fitness of
strains showing atrB and/or mfsM2 overexpression can be rather
high in field environments, but this needs further studies. We are
currently testing various fitness parameters in isogenic atrB, mrr1
and mfsM2 knock-out and overexpression strains in order to
estimate the performance of these strains. Because the natural role
of MDR-related efflux transporters seems to be the protection
against various biotic toxic compounds [14,26,28], it is possible
that the MDR strains have acquired properties that increase their
fitness in natural environments even in the absence of fungicides.
Our work is the first documented case of a massive appearance
of MDR populations in a major plant pathogen in fungicide-
treated agricultural environments. To what extent the effectiveness
of fungicide treatments against MDR strains is reduced in
comparison to sensitive strains needs to be investigated. Never-
theless, the possibilities of a further rise of MDR3 strains and of
additional mutations leading to higher levels of broad-spectrum
fungicide resistance are expected to be a major threat for chemical
control of grey mould disease in the near future.
Methods
Isolation and cultivation of B. cinerea strains
Strains were isolated from commercial vineyards in the
Champagne and the German Wine Road (Palatinate). In the
Champagne, samples were collected from vineyards located
around Moulins, Hautvillers, Vandie`res and Courteron, Moulins
being the northernmost (49u349N/03u289E) and Courteron the
southernmost (48u019N/04u269E) town, 167 km apart from each
other. Samples were collected from approximately 200 locations
each year. Each sample represented a bulk population consisting
of spores of at least 20 infected berries within the chosen plot. The
spores from each bulk sample were spread onto agar media
containing different fungicides, and analyzed for different
phenotypes as described [25,37].
In the German Palatinate, the same six vineyards were used for
sampling each year. The plots are located along the German Wine
Road, between Dackenheim (northernmost: 49u539N/8u199E) and
Walsheim (southernmost: 49u239N/8u139E), 32 km apart from
each other. Thirty isolates were obtained per vineyard from single
infected berries, resulting in about 180 isolates per year. From
each sample, HA (1% (w/v) malt extract, 0.4% (w/v) yeast extract,
0.4% (w/v) glucose, pH 5.5) cultures were grown, and terminal
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mycelial fragments cut off for subculture of isolates. Conidia
were used for fungicide tests. A list of B. cinerea strains is shown in
Table S5.
Fungicide sensitivity tests
Fludioxonil, cyprodinil (Syngenta-Agro, Maintal, Germany),
fenhexamid, tebuconazole (Bayer Crop Sciences, Monheim,
Germany), boscalid, iprodione (BASF, Ludwigshafen, Germany),
were kindly provided by the companies, carbendazim, tolnaftate
and cycloheximide were purchased from Sigma-Aldrich (St. Louis,
USA). The drugs were dissolved in 100% ethanol or 100% DMSO
(carbendazim), and added to the required concentrations to the
assays. For dilution series, fungicide stock solutions were adjusted
to keep the final solvent concentrations between 0.2 and 1.5% (v/
v) for ethanol and between 0.3 and 1.0% (v/v) for DMSO. Control
assays revealed no significant differences in growth of the strains at
these concentrations relative to no-solvent controls (not shown).
For each isolate tested, 26105 conidia were pre-incubated for
1.5 hours in 1 ml malt extract broth (pH 5.5; Difco) before use.
Effective inhibitory drug concentrations (EC50; mg/l) were
determined with 1000 spores in 0.1 ml 96-microplate cultures,
using threefold drug dilution series. Tests were performed in malt
extract broth, except for cyprodinil (Gamborg B5 minimal
medium supplemented with 10mM KH2PO4, 50mM glucose;
pH 5.5), and boscalid [38]. After 48 h (boscalid: 96 h) incubation
at 20uC, A600 was determined. The assays were repeated at least 3
times. Mean data, with standard deviations are presented. For
calculation of EC50 values, the Origin6.0 software package (Origin
Lab Cooperation, USA) was used.
Accumulation of 14C-labeled fungicides
Fungicide accumulation assays with 14C-labeled fludioxonil and
bitertanol were performed with 14 h old germlings germinated as
described previously [27]. Experiments were initiated by adding
the labeled fungicide to final concentrations of 6 mM (10 Bq/
nmol) fludioxonil, or 10 mM (10 Bq/nmol) bitertanol. The
uncoupler CCCP was added at a final concentration of 10 mM.
Three 5 ml samples each were taken 10 and 60 min after adding
the fungicide. Heat inactivation of germlings for control
experiments was performed for 10 min at 60uC. Experiments
were done in triplicates and repeated at least three times.
DNA and RNA manipulations and measurements
DNA isolation and manipulation was performed according to
established protocols. For transcript studies, B. cinerea conidia
(26106) were germinated for 15 h in polystyrene Petri dishes
coated with apple wax (0.01 mg/cm2) using Gamborg B5 medium
supplemented with 10 mM fructose and 10 mM KH2PO4
(pH 5.5). The germlings were incubated for further 30 min either
without or with 1 mg/l fludioxonil. For RNA isolation, the wax
with the embedded germlings was scraped from the surfaces with a
tissue cell scraper (TPP AG, Trasadingen, Switzerland), centri-
fuged for 5 min at 4000 rpm at 4uC, washed with 20 ml of ice-
cold water and centrifuged once more. The pellet was transferred
Figure 9. Model for the appearance of MDR phenotypes in B. cinerea vineyard populations. Regularly alternating treatments with modern
fungicides, in particular the anilinopyrimidines pyrimethanil and cyprodinil (since 1990), the phenylpyrrole fludioxonil (since 1995), and the
hydroxyanilide fenhexamid (since 2000) are assumed to be responsible for the selection of MDR phenotypes in Champagne vineyards. Repeatedly
occurring point mutations in the transcription factor gene mrr1 (blue rose symbol) lead to overexpression of the ABC transporter gene atrB (unlinked
to mrr1) and thus to MDR1 phenotype. In contrast, a unique promoter rearrangement in the MFS transporter gene mfsM2 (red asterisk) is responsible
for its overexpression and MDR2 phenotype. Strains with MDR3 phenotype, carrying both types of mutations and showing increased MDR, might
have originated either by natural MDR16MDR2 crosses or by secondary mrr1 mutations in MDR2 strains. MDR2 and MDR3 strains, and possibly also
MDR1 strains, have migrated within and out of the Champagne, reaching at least the German Wine Road region, 250 km east of the Champagne.
Further evidences for the migration are the delayed appearance of MDR2/3 strains in Germany, and the failure until now to detect them in France
outside of the Champagne. Gene expression is indicated by arrows, bold arrows indicate overexpression, and the dotted arrows with the ‘+’ sign
indicate transcription factor-mediated activation.
doi:10.1371/journal.ppat.1000696.g009
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into a mortar containing liquid nitrogen and sea sand for grinding.
Total fungal RNA was isolated using the RNeasy Plant Mini Kit
(Qiagen, Hilden, Germany), and reverse transcribed into cDNA
with oligo(dT) primers (Verso cDNA Kit; Thermo Fisher
Scientific, Surrey, United Kingdom). Northern hybridization and
quantitative RT-PCR were performed according to standard
protocols. Expression of the genes was calculated according to
Pfaffel [39]. Transcript levels were normalised against the
expression levels of housekeeping genes encoding elongation
factor 1a (BC1G_09492.1) and actin (BC1G_08198.1), and shown
as normalized fold-expression relative to expression levels of non-
induced germlings from sensitive strains. Means of at least two
biological replicates, with three strains of each phenotype, are
shown.
The following efflux transporter genes were analyzed: (Bc)atrB
[16], (Bc)atrD [18], (Bc)atrA [40], (Bc)atrF (BC1G_01454.1),
(Bc)atrK/BMR1 [16], BMR3 (BAC67160; BC1G_02799) [41],
(Bc)mfsM2 (BofuT4_P024110.1). For identification of mutations in
the mrr1 alleles of sensitive, MDR1 and MDR3 strains, mrr1
fragments were amplified from total DNA by PCR, using primers
mrr1_TF1-1 and mrr1_TF1-4, and sequenced. For identification
of the mfsM2 alleles in sensitive and MDR2/MDR3 strains, the
mfsM2 upstream region was amplified from genomic DNA by
primers mfsM2-pfor/mfsM2-prev, yielding a 1625 bp fragment
with sensitive strains, and a 2273 bp fragment with MDR2 and
MDR3 strains. For confirmation of their identity, the insertions of
6 MDR2 strains were sequenced.
Generation of B. cinerea knock-out, overexpression and
reporter fusion mutants
For atrB mutagenesis, the construct described by Vermeulen et
al. [16] was used. For mrr1 deletion, a genomic B. cinerea mrr1
fragment was amplified (primers mrr1-for1/mrr1-rev2), digested
(ApaI/SacII) and cloned into pBSKS(+). Inverse PCR was
performed (primers mrr1-rev1/mrr1-for2), the product digested
(EcoRV/XmaI) and ligated with a hygromycin cassette [42]. After
transformation into B. cinerea [43], mutants were identified with
primers mrr1-for1/tubB-inv (yielding a 1304 bp product in k.o.
mutants). For mfsM2 deletion, two mfsM2 flanking fragments were
amplified (1: mfsM2-KO1/mfsM2-KO2; 2: mfsM2-KO3/mfsM2-
KO4), digested (1: XbaI/EcoRI; 2: KpnI/XhoI), and successively
cloned into pBSKS(+). The hygromycin cassette from pLOB1
(AJ439603) was inserted between the fragments via EcoRI and
XhoI. The construct was amplified (primers mfsM2KO/mfsM2-
KO4) and transformed into MDR2 strains D06.6-5 and D06.2-6.
The DmfsM2 mutants were confirmed by PCR (primers mfsM2-
KO1/oliC-Sma-Rev), yielding a 1605 bp product in k.o. mutants.
To construct strains expressing an mrr1 allele conferring MDR1,
mrr1V575M of strain D06.7-27 was amplified (primers mrr1-atg/
mrr1-uaa), digested (XmaI/PvuII) and cloned into pBSKS(+)
carrying a 59-fragment of the hygromycin resistance gene driven
by the oliC promoter [44]. Additional 1578 bp of the mrr1
upstream region were amplified (primers mrr1-pro1/mrr1-rev1),
digested (BamHI/XmaI) and ligated next to mrr1V575M. The
resulting plasmid was linearized (KpnI) and transformed into B.
cinerea B05.Hyg-3 [44]. To generate mfsM2 overexpression strains
(mfsM2ox), mfsM2 was fused to the oliC promoter. The mfsM2
coding sequence was amplified (primers mfsM2-ATG-SmaI/
mfsM2-TAG-EcoRI), digested (SmaI/EcoRI) and ligated into
poliGUS-Hyg5, replacing uidA. poliGUS-Hyg5 was constructed
by fusing an oliC promoter fragment from pLOB1 (primers KO-
Hyg1-BamHI/oliC-Sma-Rev), an uidA coding sequence from
p35S-GUS [45] (primers 35S-gus-for-Sma/35S-gus-rev-Eco), the
B. cinerea niaD terminator (primers niaDTerm-for-Eco/niaDTerm-
rev-Hind) and the 59 part of a splitted hygromycin resistance
cassette from pBS.Hyg-5 [44] (HindIII/XhoI) into pBSKS(+). The
resulting plasmid was linearized (KpnI) and transformed into strain
B05.Hyg-3, yielding B05.Hyg-3(mfsM2ox). To construct mfsM2
promoter-reporter fusions, the oliC promoter fragment in poli-
GUS-Hyg5 was replaced either by a 1501 bp mfsM2 upstream
fragment from strain B05.10, or by a 2149 bp fragment from
MDR2 strain D08.2-12 including the 1326 bp retrotransposon-
derived fragment and the remaining mfsM2 upstream region
(primers mfsM2-pfor-Not/mfsM2-prev-Sma), before transforma-
tion into B05.Hyg-3. B. cinerea B05.Hyg-3 transformants were
analyzed for correct genomic integration of the constructs by
PCR. GUS staining of transformants was performed as described
[46].
Field competitiveness of an MDR strain in a fungicide-
treated vineyard
MDR3 strain D06.7-33 and the sensitive (BenR) strain D06.5-25
were chosen for a mixed-inoculation experiment, performed twice
in 2007 and 2008 in experimental vineyards at the German Wine
Road (Neustadt an der Weinstrasse). In June (berry stage BBCH-
77) the vineyards received a standard treatment with Teldor. In
summer, immature grapes (stage BBCH-81) were inoculated,
using hand spraying bottles, with a 1:1 strain mixture (26104
conidia/ml per strain) in water until runoff. The vineyards were
randomly divided into three fungicide-treated and three untreated
plots. The first inoculation was one day before, the second one day
after standard treatment with Switch in the treated plots, and in
the same way in non-treated plots. Before grape harvest at late
September, 50 (2007) and 90 (2008) isolates per plot were
recovered from moulded berries from the inoculated plots and
from a non-inoculated, untreated control plot nearby. The
introduced isolates were identified by fungicide tests, using HA
plates containing 0.2 mg/l fludioxonil, 5 mg/l iprodione, or
5 mg/l carbendazim. In the control plot, MDR3 strains were
never detected, while BenR strains were found with frequencies of
12% (2007) and 6% (2008). Their genetic identity was further
confirmed by IGS-AFLP markers [31]. For analysis of the
overwintered populations, B. cinerea isolates were recovered in
the following spring from bark fragments of inoculated grapevines
(2008: 137; 2009: 313 isolates), by incubation on a selection
medium for B. cinerea [47], followed by fungicide tests.
Statistics
Experiments were performed at least three times, unless
indicated otherwise. Statistical differences of data were checked
by unpaired, two-tailed t tests, and labeled as follows: n.s.: not
significant; * p,0.05; ** p,0.01; *** p,0.001. In the graphs,
standard deviations are indicated.
Accession numbers
The DNA sequence reported in this paper has been deposited
in GenBank, under accession number GQ292709 (RE-like
gene fragment inserted in mfsM2). Further accession numbers:
mfsM2: BofuT4_P024110.1; mrr1: BofuT4_P063510.1 (http://
urgi.versailles.inra.fr/projects/Botrytis/).
Supporting Information
Figure S1 Similarity between the retroelement-like sequences in
the mfsM2 promoter of B. cinerea MDR2 and MDR3 strains and in
other fungal retrotransposons. Alignment of the translated retro-
element-derived gene fragment in the mfsM2 promoter region of
MDR2 and MDR3 strains with predicted reverse transcriptase-
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RNase H sequences from the REAL [32] (Alternaria alternata; acc.
BAA24352; 551 amino acids) and Boty [33] (B. cinerea; acc.
XP_001548698; 1618 amino acids) retrotransposons. Conserved
reverse transcriptase (RT) and RNase H domains are marked.
Dashes: No amino acids.
Found at: doi:10.1371/journal.ppat.1000696.s001 (0.54 MB TIF)
Table S1 B. cinerea crosses. Crosses were performed for map-
based cloning of the MDR1 regulator, mrr1 (multidrug resistance
regulator 1), and mapping of mfsM2 (major facilitator superfamily
transporter involved in MDR2) in MDR2 and MDR3 strains.
Conformity of the observed segregation data with the involvement
of single dominant genes for MDR1 (cross 1) and MDR2 (cross 2),
and for two independently segregating, codominant genes for
MDR1, MDR2 and MDR3 (crosses 3, 4) was analyzed by x2 test,
with x2 values calculated for p = 0.05. #Consistent with
segregation of two co-dominant genes. Cross 4 showed a deviation
from the expected 1:1:1:1 segregation. The reason for this is not
clear. An explanation could be unequal survival of the progeny
strains, because some of the strains analyzed showed very slow
growth.
Found at: doi:10.1371/journal.ppat.1000696.s002 (0.04 MB RTF)
Table S2 Molecular markers showing linkage of mrr1 with
MDR1 phenotype. The markers were generated by searching for
polymorphic microsatellites (MS) in the genomes of B. cinerea
strains B05.10 (http://www.broad.mit.edu/) and T4 (http://
urgi.versailles.inra.fr/gbrowse/cgi-bin/gbrowse/BOTRYTIS_T4).
Length polymorphisms of the PCR-amplified marker fragments
between the parent strains of crosses 1, 3 and 4 were detected by
agarose gel electrophoresis. A total of 24 polymorphic MS markers
were initially used for screening the F1 progeny strains derived from
crosses 1, 3 and 4, revealing markers BC218 and BC274 as
cosegregating with MDR1. Markers BC294-2 and BC63-17 were
subsequently generated for fine-mapping of the MDR1 locus.
Because mutations leading to overexpression of efflux transporter
genes and MDR in Candida albicans have been located in
transcription factor genes [13,30], the transcription factor gene
mrr1 which showed the closest linkage with MDR1 in the B. cinerea
genome, was selected for further analysis. *Fragments obtained after
digestion with SacI.
Found at: doi:10.1371/journal.ppat.1000696.s003 (0.03 MB RTF)
Table S3 Molecular markers confirming linkage of mfsM2 to
MDR2 and MDR3 phenotypes. Based on evidence that mfsM2
mutations are responsible for the appearance of MDR2 and
MDR3 phenotypes, markers located close to mfsM2 were
analyzed. The markers are polymorphic between the parent
strains of the indicated crosses. * Fragments obtained after
digestion with HindIII.
Found at: doi:10.1371/journal.ppat.1000696.s004 (0.03 MB RTF)
Table S4 Sequence polymorphisms of mrr1 in B. cinerea strains
with different MDR phenotypes. All nucleotide exchanges (top
row) in the mrr1 coding region leading to amino acid changes
(second row) and silent exchanges relative to the sequences of the
sensitive reference strains B05.10 and T4 are shown. To the strain
names, the phenotypes are added. D23A24P: 6 bp deletion in the
mrr1 coding region, leading to deletion of two codons encoding Ala
and Pro. Seven sensitive field strains from Palatinate vineyards had
the same Mrr1 sequence as strains T4 and B05.10. Neither the
D23A24P deletion in several but not all MDR1 strains, nor the
conservative V227I exchange in MDR2 strain IXa14 are likely to
alter the properties of Mrr1.
Found at: doi:10.1371/journal.ppat.1000696.s005 (0.20 MB RTF)
Table S5 B. cinerea strains used in this study. BenR, ImiR: Strains
resistant to benzimidazoles and the dicarboximide iprodione,
respectively. If tested, the mrr1 and the mfsM2 alleles are indicated.
HygR, PhleoR: Transformation-mediated resistance to hygromycin
and phleomycin, respectively. 1Derived from a cross between
strains 4.33.10b (MDR1, isolated in the Champagne in 1994) and
SAS56. 2Derived from a cross between strains SAS405 and B.692
(MDR2, isolated in the Champagne in 1994) and strain SAS56.
3Site of isolation within the Champagne unknown. n.t.: not tested.
Rearrangement of the mfsM2 promoter was tested either by
sequencing (mfsM2seq(+): rearranged; mfsM2seq(2): not rearranged)
or by PCR (mfsM2pcr(+) or mfsM2pcr(2)).
Found at: doi:10.1371/journal.ppat.1000696.s006 (0.15 MB RTF)
Table S6 Oligonucleotide primers used in this study. Introduced
restriction sites are underlined.
Found at: doi:10.1371/journal.ppat.1000696.s007 (0.08 MB RTF)
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